Navitas Life Sciences joins the National Coordination Centre, Indian Pharmacopoeia Commission in celebrating National Pharmacovigilance week 17-23rd September 2021.
Here is how Navitas Life Sciences Defines Key Aspects on Building a resilient Future
Dr. Manish Harsh, Vice President, Clinical data Services provides key insights about the impact of technology on efficient clinical data management
A Market Authorization Holder (MAH) appoints a Qualified Person responsible for Pharmacovigilance (QPPV) to market drug products in the European Union (EU)...
Regulatory Affairs play a pivotal role in bringing new drug products to the market swiftly. However, it is often perceived
In the everchanging clinical trial landscape, a sustainable quality management system is imperative. The Pharmaceutical Quality for the 21st Century
Dr. Latika Sharma, Head PV Networks, Navitas Life Sciences shares expert insights about staying ahead in Pharmacovigilance
August is National Immunization Awareness Month, supported by the U.S Centers for Disease Control and Prevention (CDC),
Navitas Life Sciences has been supporting efficient clinical trials for over 30 years, partnering with small to large pharmaceuticals,
Several times during a clinical trial, experts work along with sponsors to strategize with the best intentions to assess clinical trial progress